Discussing the Big Ideas in Medicine Manufacturing: Part II featuring Likarda
More experts share their thoughts on the next “big ideas” that they think will shape the near future of therapy developments.
Stella K. Vnook, CEO, Likarda
“The next big idea in medicine manufacturing isn’t a single technology — it’s the intelligent integration of biology, automation, and data. In cell and regenerative therapy manufacturing, we’re now using AI not just for predictive modeling but for real-time decision making.
“Automation is redefining scalability: modular microfactories and closed-loop encapsulation systems allow complex biologics and living therapies to be produced closer to the point of care. What was once a centralized, fragile supply chain is evolving into a distributed, data-driven manufacturing ecosystem.
“Sustainability follows naturally – by reducing cold-chain dependency, optimizing media utilization, and enabling reusability of bioreactors, AI-driven automation is cutting waste and cost while increasing accessibility. The future of medicine manufacturing lies in adaptive systems – intelligent, self-correcting platforms that make cell therapy as scalable and reliable as conventional pharmaceuticals.”
